Design, synthesis, characterization and toxicity studies of Poly (N-Iso-Propylacrylamide-co-Lucifer Yellow) particles for drug delivery applications by Mohsen, R. et al.
Greenwich Academic Literature Archive (GALA)
– the University of Greenwich open access repository
http://gala.gre.ac.uk
__________________________________________________________________________________________
Citation for published version:
Mohsen, R., Alexander, B. D., Richardson, S. C. W., Mitchell, J. C., Diab, A. A. and Snowden, M. J. 
(2016) Design, synthesis, characterization and toxicity studies of Poly (N-Iso-Propylacrylamide-co-
Lucifer Yellow) particles for drug delivery applications. Journal of Nanomedicine and Nanotechnology, 
7 (2):1000363. pp. 363-372. ISSN 2157-7439 (doi:10.4172/2157-7439.1000363) 
Publisher’s version available at:
http://dx.doi.org/10.4172/2157-7439.1000363
__________________________________________________________________________________________
Please note  that  where  the  full  text  version provided on GALA is  not  the  final  published 
version, the version made available will be the most up-to-date full-text (post-print) version as 
provided by the author(s).  Where possible, or if citing, it is recommended that the publisher’s  
(definitive) version be consulted to ensure any subsequent changes to the text are noted.
Citation for this version held on GALA:
Mohsen, R., Alexander, B. D., Richardson, S. C. W., Mitchell, J. C., Diab, A. A. and Snowden, M. J. 
(2016) Design, synthesis, characterization and toxicity studies of Poly (N-Iso-Propylacrylamide-co-
Lucifer Yellow) particles for drug delivery applications. London: Greenwich Academic Literature 
Archive.
Available at: http://gala.gre.ac.uk/15098/
__________________________________________________________________________________________
Contact: gala@gre.ac.uk
Research Article Open Access
Journal of
Nanomedicine & NanotechnologyJou
rn
a
l 
o
f 
N
an
om
edicine & Nan
o
te
c
h
n
o
lo
g
y
ISSN: 2157-7439
Mohsen et al., J Nanomed Nanotechnol 2016, 7:2
http://dx.doi.org/10.4172/2157-7439.1000363
J Nanomed Nanotechnol
ISSN: 2157-7439 JNMNT, an open access journal
Volume 7 • Issue 2• 1000363
Design, Synthesis, Characterization and Toxicity Studies of Poly (N-Iso-
Propylacrylamide-co-Lucifer Yellow) Particles for Drug Delivery 
Applications
Mohsen R1,2*, Alexander BD1, Richardson SCW1, Mitchell JC1, Diab AA2 and Snowden MJ1
1School of Science, University of Greenwich, Chatham, Kent, ME4 4TB, UK
2Faculty of Biotechnology, October University for Modern Sciences and Arts (MSA), Cairo, Egypt
Abstract
A novel luorescent temperature/pH responsive particle was designed, synthesized, characterised and tested for 
toxicity. Poly (N-iso-propylacrylamide-co-5%-lucifer yellow) (p(NIPAM-co-5% LY)) was prepared using a surfactant 
free emulsion polymerisation technique. The particles were negatively charged and were approximately 250 nm at 
15°C. When the particles de-swell following an increase in temperature, a particle size around 100 nm is obtained. The 
toxicity of different concentrations of the new particles (p(NIPAM)-co-5% LY, as well as the 100% p(NIPAM) and the 
main monomer NIPAM was tested on two cell lines (Hela and Vero). The toxicity was tested in comparison to a positive 
control (dextran sugar) and a negative one (poly(ethylenimine)) (PEI). The results show that the two particles show cell 
viability over 80% (for both cell lines Hela and Vero) up to a concentration of 3 mg/mL while NIPAM monomer showed 
cell viability over 80% at a concentration equal to or less than 0.3 mg/mL. The luorescence property of the novel 
particles make them traceable. Combining this property (tracing) to the ability of the particles to release their content in 
response to temperature and pH change can be a potential drug delivery system for cancer treatment. 
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Introduction
Poly (N-isopropyl acrylamide) (p(NIPAM)) particles are 
characterised by their ability to change their conformation and 
physico-chemical properties (such as particle size and surface charge 
density) according to the change in the surrounding environment such as 
temperature, pH and ionic strength [1-5]. his is thought to be a property 
that can be used in diferent applications such as drug delivery [6]. 
Below the volume phase transition temperature (VPTT), the 
polymer-polymer and polymer-solvent interactions are weak, the 
interstitial spaces in the nanogel particles are illed with water and the 
nanogel particles are swollen. Above the VPTT, the polymer-polymer 
interactions become stronger than the polymer-solvent ones and so the 
polymer particles tend to collapse (Figure 1). When the temperature is 
increased, the polymer chains tend to interact with each other rather 
than with the solvent molecules and the hydrogen bonding between the 
polymer chains and the solvent molecules is reduced. his causes most 
of the solvent entrapped within the interstitial spaces of the polymer 
matrix to be expelled; forming hard like sphere particles and the 
nanogel tends to shrink. During this collapsed state, the particles are 
dispersed; this is due to the repulsion between the similar ionic charges 
on the particle surface caused by the ionic initiators. his process 
(deswelling) is reversible, so if the temperature goes back below the 
VPTT, the interactions between the polymer and the solvent improve 
and the nanogel swells again. 
he fact that the volume phase transition temperature (VPTT) of 
NIPAM based nanoparticles (32-34°C) [3] is very close to the human 
body temperature (37°C) makes them a good choice for biomedical 
applications. As an example of suggested drug delivery applications 
based on temperature trigger, the particles are swollen at room 
temperature (around 25°C which is below the VPTT), so, if they 
incorporate a drug in its matrix, when administered in the human body 
VPTT, it will deswell and release the drug. Many researchers suggested 
drug delivery [7-9], diagnostics [10] and protein binding [11-13] 
applications of NIPAM-based nanoparticles. 
Nanogels sensitive to both temperature and pH can be prepared 
by incorporating acidic or basic co-monomers into poly (NIPAM) 
nanogel matrix. An example of this is the poly (NIPAM)-co-acrylic 
acid nanogel [1]. Figure 1 shows the efect of temperature and pH 
on the temperature/pH sensitive p(NIPAM)-co-acrylic acid particles. 
At temperature lower than the VPTT, the particles take in solvent 
molecules (water) and hydrogen bonds are formed between them (the 
particles and the water molecules). When the temperature exceeds 
the VPTT, the hydrogen bonds are broken and the particles collapse 
(Figure 1) [1]. he pH conformational transition point depends upon 
the logarithm of the acid dissociation constant (pK
a
) of the functional 
groups incorporated. At pH below the pK
a
 of acrylic acid, the nanogel 
particles are collapsed (due to low electrostatic repulsion forces (E.R.F) 
but when the pH is more than the pK
a
, the E.R.F. between the ionised 
acrylic acid molecules within the polymer matrix increase causing the 
gel to acquire a more swollen coniguration (Figure 1). In Figure 1, the 
blue colour represents low temperature (below the VPTT) and high pH 
(higher than the pK
a
), the red colour represents high temperature and 
low pH. Both cases (low temperature/low pH and high temperature/
high pH) are represented as light blue.
he incorporation of a luorescent dye such as Lucifer yellow (LY) 
to p(NIPAM) particles adds a new function (colour and luorescence) 
that makes it traceable. his suggests new applications especially in 
the ield of diagnosis of diferent diseases either in vivo or in vitro. 
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Combining the previously suggested drug delivery applications of 
nanogels [7-9] to its ability to being traced in the human body can be 
a promising system for combined diagnosis and delivery of drugs to 
suitable environments [14,15]. 
In this work, a novel nanoparticle, p(NIPAM-co-5% LY), 
is synthesized and characterized using DLS (particle size and 
electrophoretic mobility), infrared spectroscopy, scanning electron 
microscopy and luorescence microscopy. Being a candidate for 
biomedical applications, the toxicity was tested using two cell lines: 
kidney cells (Vero) and breast cancer cells (HeLa). 
Lucifer yellow VS 
Lucifer yellow VS dilithium is a water soluble luorescent dye of 
molecular weight 550.39 g/mol [16]. Due to the presence of 3 benzene 
rings, it is hydrophobic in nature. It has two excitation wavelengths 
(430 and 280 nm) and emission wavelength at 540 nm [17]. Lucifer 
yellow is used for diferent biomedical applications including marking 
cells, neurons, albumin, cholesterol, phospholipids, collagenase, 
polynucleotides, progesterone derivatives, testosterone, estriol [16], 
and tracers of cell-cell fusion [18]. It is also selectively binds to copper 
[19] which can be used in industrial and environmental applications.
he logarithm of acid dissociation constant (pK
a
) of LY was 
calculated using the online database ACD/labs [20]. he presence of 
more than one ionisable group in the molecular structure of LY (Figure 
2) results in more than one pK
a
, these are; -2.2 (0.6), -0.7 (0.5), 1.4 (0.8) 
and 5.7 (0.8) where standard deviations are shown between brackets. 
Figure 2 shows the protonation state of LY versus pH. he most acidic 
form is coloured red and the most alkaline one is coloured blue. 
he two negative pK
a 
values are mainly caused by the protonation/
deprotonation of the sulphonate groups (groups 1 and 2 (coloured in 
red)) (Figure 2). he irst positive pK
a 
is caused by the protonation/
deprotonation of the nitrogen in the piperidine ring (group 3 (coloured 
in light blue)) while the second one is caused by the amino of the aniline 
(group 4 (coloured in blue)) [1]. An overview of the protonation state 
of lucifer yellow at diferent pH values is shown in Figure 3 [1]. 
From polymerization point of view, lucifer yellow VS dilithium salt 
is a perfect choice. his is due to the presence of a pendant vinyl group 
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Figure 1: A schematic diagram representing the effect of temperature and pH 
on a typical temperature/pH responsive microgel particle.
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Figure 2: Molecular structure of lucifer yellow VS dilithium salt [2].
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Figure 3: Protonation state of lucifer yellow versus pH [1].
(coloured in grey) (Figure 2) which makes it readily polymerizable 
with other monomers under suitable conditions. his is important for 
synthesizing monodispersed particles with the similar electrophoretic 
mobilities. On the other hand, a disadvantage of using lucifer yellow 
is its relatively low molar extinction coeicient (ɛ) of 12000 M-1 cm-1 
[17,21,22] when compared to other luorophores such as luorescein 
isothiocyanate (FITC) with a molar excitation co-eicient of 75000 M-1 
cm-1 [23], texas red (ɛ = 85000 M-1 cm-1 [24] and tetramethyl rhodamine 
isothiocyanate (TRITC) with an ɛ of 100000 M-1 cm-1 [23]. It is also 
characterised by a relatively low quantum yield (21%) [25] compared 
to other luorophores such as rhodamine 6G (95%), luorescein (95%) 
and quinine sulphate (58%) [26]. 
Materials and Methods
Materials
N-isopropylacrylamide (NIPAM) 97% (Aldrich), lucifer yellow 
(LY) (Aldrich), N, N’-methylenebisacrylamide 99% (Aldrich), 
potassium persulphate 98% (BDH Laboratory Suppliers), branched 
poly(ethylenimine) (PEI) of molecular weight 25 kD (Cat. 18197-8) 
(Aldrich) were obtained from commercial suppliers and used without 
further puriication. Vero CCL-81 (normal kidney of Cercopithecus 
aethiops) and HeLa CCL2 (human cervical epithelial cells) from ATCC 
company. Media were purchased from Gibco Life Technologies. 
For Vero cells, Dulbecco’s Modiied Eagle Medium (DMEM) was 
used while for HeLa cells, Minimum Essential Medium (MEM) was 
used. Penicillin-Streptomycin-Glutamine (PSG) (100x) and fetal 
Bovine Serum (FBS) were purchased from Gibco life technologies. 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) was purchased from Sigma Aldrich UK. 
Methods
Synthesis of p(NIPAM-co-5% LY): In a 1 L reaction vessel, 0.5 g 
of the initiator (potassium per sulphate) was dissolved in 800 mL of 
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dilution) to a 500 mL media bottle (either DMEM or MEM). Media 
were kept in the fridge at 4°C.
Cell sub-culturing: In a clean and sterile class II laminar low hood, 
the media in the lask were removed using a disposable sterile 10 mL 
serological pipette (Fisher brand). he lask was then washed with 10 
mL of sterilised phosphate bufered saline (PBS) 3 times (using a new 
serological pipette each time). Trypsin EDTA (0.5 mL) was added and 
spread among the lask which is then placed in an incubator (hermo 
Scientiic HERACELL 150i CO
2
 incubator) at 37°C and 5% CO
2
 v/v 
for 5-7 minutes ater which the viability of cells was checked under 
microscope (Nikon Japan with a х10 ELWD lenswith working distance 
2.62–1.8 mm). Ater that, 10 mL of fresh media (MEM for HeLa and 
DMEM for Vero cells) were added to the lask and well mixed with 
the cells, and then 9 mL of the media (now mixed with cells) were 
removed and put in an Eppendorf tube to be used for the seeding step. 
Fresh media (9 mL) were then added to the lask, mixed then put in the 
incubator. Cells were split twice weekly. 
Cell seeding: Cell count (using a haemocytometer) of the cell 
suspension from the splitting step (9 mL removed ater using trypsin) 
was carried out. Accordingly, a cell suspension of a concentration (1 × 
104 cell/mL) was prepared. In a 96-well plate (excluding the peripheral 
cells, these are columns 1 and 12 and rows A and H (Figure 4)), 100 µL 
of the freshly prepared cell suspension were placed in each well. he 
plate was then put in the incubator for 24 hours. 
Sample preparation: In an autoclaved beaker, the sample (either 
dextran, NIPAM monomer, p(NIPAM), p(NIPAM-co-5% LY) or PEI) 
is weighed. Sterile fresh media (MEM for HeLa and DMEM for Vero 
cells) was added and let stirring for an hour. In a sterile class II laminar 
low hood, the sample dispersion/solution was iltered using a single 
use ilter unit with a pore size of 2 µm (Minisart® Sartorius stedium 
biotech). A serial dilution was then prepared and used for cell dosing.
Cell dosing: he previously seeded 96-well plates are placed in a 
clean and sterile fume cupboard, the 100 µL of media (in each well) are 
removed using sterile pipette tips. he irst two columns are used as 
control wells (100 µL of fresh media is put in each well) while the rest 
of the columns is used for the diferent concentrations of the sample. 
In each well, 100 µL of the pre-prepared sample-media suspension is 
accurately put using a sterile pipette tip. For each sample, two plates are 
set up; Figure 4 shows the design of each plate while Table 1 shows the 
concentrations used in each one. For each cell line (HeLa and Vero), 
a whole plate was set up to be a control one. Plates are placed in the 
incubator for 72 hours ater which the MTT assay is carried out. 
distilled water. A three-necked lid was clamped to the reaction vessel, 
which was then heated to 70°C with continuous stirring. Monomer 
(4.75 g NIPAM), co-monomer (0.25 g lucifer yellow (LY)) and cross 
linker (0.5 g N,N’-methylenebisacrylamide) were stirred in distilled 
water (200 mL) and transferred into the reaction vessel containing the 
initiator and continuously stirred at 70°C for six hours under an inert 
atmosphere of nitrogen. When the reaction was complete, the nanogel 
dispersion was allowed to cool to room temperature. he nanogel 
was dialyzed in fresh de-ionised water for a week (changed daily), 
centrifuged and freeze dried. 
Dynamic light scattering (DLS): Dynamic light scattering (DLS) 
measurements were carried out using a Malvern Zetasizer Nano ZS. 
he hydrodynamic diameter of the particles was measured in response 
to temperature in the 15 to 60°C range. All samples were diluted with 
deionized water (1 mL of dialysed microgel dispersion was diluted 
with 2 mL of water) before measurements. A quartz cuvette with two 
polished windows (Starna Type 1) was used for all the measurements 
and the temperature of the dispersion was controlled by a Peltier 
thermocouple. Data for p(NIPAM-co-5% LY) measurements were 
collected every 1°C and the samples were equilibrated for 2 min before 
each data collection point. hree measurements, each consisting 
of 13 subruns, were taken at each temperature to obtain an average 
hydrodynamic diameter. Experiments were also conducted where 
the pH of the samples was adjusted to diferent pH values using HCl 
and NaOH to test for the efect of changing pH upon the size of the 
particles. he electrophoretic mobility of p(NIPAM-co-5% LY) in 
a salt concentration of 1 x10-4 M NaCl was measured in response to 
temperature change across the range of 15-60°C using a disposable 
folded capillary cell. 
Fluorescence spectroscopy: A Horiba Jobin Yvon Fluoromax 4 
spectroluorometer was used for luorescence experiments. All samples 
were excited at 430 nm and the full emission spectra (450–1050 nm) 
were recorded with bandwidth of 5 nm at 25°C. A 10 mm path length 
quartz cuvette with four polished windows (Starna Type 3) was used 
for all the measurements.
Infrared spectroscopy (IR): A hermo Nicolet Nexus FT-IR 
was used to carry out the IR experiment in this work. Nanoparticle 
dispersions were dialysed and freeze-dried then the solid samples 
(powder) were used for IR experiments using attenuated total relection 
(ATR) ZnSe crystal. 
Microscopy
Scanning electron microscopy: A Hitachi SU8030 cold cathode 
illed emission gun scanning electron microscope was used to obtain 
images of the particles.
Fluorescence microscopy: A Nikon Eclipse 90i microscope, itted 
with a luorescein isothiocyanate ilter (FITC) and a Nikon digital sight 
DS-U3 camera were used to take luorescent images of the particles. 
Plan Fluor 100x oil Ph3 DLL lens was used with working distance of 
0.16 mm. he numerical aperture of the images was 1.3, refractive index 
1.5 and exposure time 3 s. the sample was placed on a microscopic slide, 
let to dry in air and then immersion oil was added on it. 
Toxicity studies 
Sterilization: All the pipetting tips, phosphate bufered saline 
(PBS), glassware, magnetic stirrers, spatulas used in this experiment 
were sterilized used an Astell autoclave at 121°C for 85 minutes.
Preparation of media: To prepare a complete media, 50 mL PSG 
(100x) and 5 mL Fetal Bovine Serum (FBS) were added (without any 
 
C C A1 A2 A3 A4 A5 A6 A7 A8 
Figure 4: Structure and organisation of the 96- well plates used for toxicity 
studies. Blue cells were kept empty. The concentrations of the columns are 
shown in Table 1.  
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he concentrations of the columns are shown in Table 1. 
MTT assay: For the preparation of MTT solution, 250 mg of MTT 
reagent were dissolved in PBS and sterilised at 121˚C for 85 minutes. 
In each well, 10 µL of pre-prepared of MTT solution was added. Plates 
were then placed in the incubator and let for 4 hours. he media was 
then removed (this includes 100 µL sample in media and 10 µL MTT) 
and 100 µL of dimethyl sulphoxide (DMSO) are added in each well 
and plates are let in the incubator for 30 minutes. he absorbance at 
540 nm of the DMSO in each well is then determined using a hermo 
Electron Corporation Multiskan Ascent plate reader. 
Growth curves: Cells were seeded at a concentration of 1 × 104 cell/
mL (as explained above) in a 96-well plate. Every day (for 10 days), 
MTT assay was carried out (as explained above) on one column of the 
plate. 
Results and Discussion
Particle size
Efect of temperature on the particle size: Figure 5 shows the 
response of p(NIPAM-co-5% LY) to the change in temperature across 
a temperature range of 15-60°C both during heating and cooling. he 
initial particle size at 15°C at pH 7 is 250 nm which is considerably 
smaller than that of 100% p(NIPAM) with an initial particle size of 550 
nm [3,27]. he incorporation of a hydrophobic co-monomer such as 
lucifer yellow [28] decreases the extent of hydrogen bonding between 
the particle and water (solvent) compared to 100% p(NIPAM), so, less 
water will be incorporated in the particle leading to a smaller particle 
size [29]. It also changes the reaction conditions such as the rate of the 
reaction, solubility of the monomer and co-monomer and the extent 
of reaction before termination [30]. he DLS data suggest that LY was 
successfully incorporated in the new particle. he Figure also shows that 
the novel luorescent nanoparticle maintains the reversible temperature 
responsive behaviour of p(NIPAM) with a VPTT comparable to that 
of 100% p(NIPAM) which is 35°C [3]. he polydispersity index (PdI) 
value (Figure 5), which is close to zero (0.04), suggests that the majority 
of the particles in the dispersion acquire an even size. 
Efect of pH on the particle size of p(NIPAM)-co- 5% LY: he 
efect of pH on the hydrodynamic diameter of p(NIPAM-co-5% LY) is 
shown in Figure 6. he Figure shows an increase in the particle size by 
increasing the pH at the same temperature (25°C). At pH (0.5-3), the 
particle diameter was 190 nm and increased by 20% to reach 230 nm 
at pH (5-10). At pH 11, the particle further swells by 9% to reach 248 
nm. he change in particle size is thought to be mainly attributed to the 
change of the protonation state of the co-monomer lucifer yellow by 
the change in pH (Figure 3). 
Several pH sensitive NIPAM based particles (with diferent co-
monomers such as acrylic acid) have been studied [3]. At pH lower 
than the pK
a
 of the co-monomer, the anionic groups are protonated, 
accordingly, they are not charged and hence the electrostatic repulsion 
force is minimal. When the pH increases above the pK
a
 of the co-
monomer, the anionic co-monomer groups are deprotonated, creating 
more surface charge on the particle, leading to more electrostatic 
repulsion forces and hence the increase in the particle size. 
Lucifer yellow VS shows two positive pK
a
 values (1.4 (0.8) and 5.7 
(0.9)) [1]. Figure 6 shows the change in the hydrodynamic diameter of 
p(NIPAM)-co-5%LY according to the change of pH. he irst positive 
pK
a
 of LY (1.4) (caused by the deprotonation of the nitrogen of the 
piperidine ring) [1] shows a minimal efect on the particle size (Figure 
6). Comparing the particle size at pH 0.5 to that at pH 3 shows minimal 
change in the particle size at the two cases. An increase in the particle 
size around the pH of 5 which is in the range of the second positive pK
a
 
of LY (caused by the deprotonation of the amino group (Figures 2 and 
3) [1] is observed. he Figure shows 23% increase in particle size by 
increasing the pH from 3 to 5. 
At pH below 5.7 (± 0.9), p(NIPAM)-co-5% LY can be considered as 
a zwitterionic particle. he negative surface charge on p(NIPAM-co-5% 
LY) particles is caused by the SO
4
- groups from the anionic initiator 
used during the particle synthesis (K
2
SO
4
) and the luorescent dye 
(lucifer yellow) with sulphonate groups (Figure 2). Having two negative 
pK
a
 values, the sulphonate groups of lucifer yellow are deprotonated 
when the pH is above zero (Figures 2 and 3) [1]. At pH below 1.4, 
the nitrogen group of the piperidine ring and the amino group of the 
aniline are both protonated creating positive charge that masks some of 
the negative charge created by the initiator and the sulphonate groups 
of LY. At 1.4 < pH > 5.7, the nitrogen of the piperidine is deprotonated, 
but the tertiary amine group of the aniline is protonated and thus 
charged, so, positive charge caused by the protonated amino group 
Conc. C C A1 A2 A3 A4 A5 A6 A7 A8
Plate A
mg/mL Control Control 3.00 1.00 0.70 0.30 0.10 0.07 0.03 0.01
Plate B
µg/mL Control Control 7.00 3.00 1.00 0.70 0.30 0.10 0.07 0.03
Table 1: The design of plates A and B and the concentrations used for the 
toxicity testing of dextran, NIPAM monomer, p(NIPAM), p(NIPAM-co-5% LY) and 
poly(ethylenimine) (PEI).
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Figure 5: The effect of temperature on the particle size of p(NIPAM-co-5% LY) 
at pH 7 across temperature range (15-60°C).
150
170
190
210
230
250
270
290
0 2 4 6 8 10 12
D
h
(n
m
)
pH
Figure 6: The effect of pH on the hydrodynamic diameter of p(NIPAM)-co-5% 
LY at 25°C.
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can still mask some of the negative charges. When the pH exceeds 5.7 
(± 0.9), both groups (nitrogen of piperidine and amino of aniline) are 
deprotonated and thus no positive charges are created. At this point, 
the negative surface charge on p(NIPAM)-co-5% LY is maximal and 
not masked by positive charges (the particle is not zwitterionic anymore 
and tends to only carry negative charges on its surface. his increases 
the electrostatic repulsion within the particle and hence increases the 
particle size (Figure 5). 
It is worth mentioning that the magnitude of change in the 
particle diameter of p(NIPAM)-co-5% LY at diferent pH values is less 
than that of previously known temperature/pH responsive particles 
such as p(NIPAM)–co-5% AA [3]. he initial particle diameter of 
p(NIPAM)–co-5% AA at 15˚C at pH 3 is 290 nm while at pH 6 (at 
the same temperature) is 550 nm [3]. his shows a 90% increase in 
the particle size by changing the pH of the particle dispersion. In the 
case of p(NIPAM-co-5% LY), the particles only show a 32% increase in 
diameter when the pH is changed from 0.5 to 11. 
he magnitude of particle size change in response to pH change 
can be increased by incorporating another co-monomer. his has been 
carried out by many researchers such as the incorporation of AA (3), 
N-t-butylacrylamide [31].he suggested result then is the synthesis of a 
luorescent temperature/pH sensitive particle with a higher magnitude 
of pH sensitivity. 
Electrophoretic mobility
Efect of temperature on the electrophoretic mobility: Figure 
7 compares between the electrophoretic mobility of p(NIPAM) and 
p(NIPAM)-co-5% LY. p(NIPAM) has a negative surface charge due 
to the anionic initiator (potassium persulphate) used during synthesis 
while p(NIPAM)-co-5% LY has a negative surface charge due to both 
the initiator and the anionic co-monomer (LY) [32].
he Figure shows that at 15°C the electrophoretic mobility of 
p(NIPAM-co-5% LY) (-0.32 µmcm/Vs) is higher than that of p(NIPAM) 
(-0.17 µmcm/Vs). his can be attributed to two main reasons; irst, the 
presence of a higher surface charge density on p(NIPAM-co-5% LY) 
particles due to the addition of an anionic co-monomer (lucifer yellow) 
[32] beside the anionic initiator (potassium persulphate) used during 
the synthesis. Second, is that the particle size of p(NIPAM-co-5% LY) 
is smaller than that of p(NIPAM) which causes the particles to move 
faster. When the temperature exceeds the VPTT (35°C), the particle 
deswells which results in a higher surface charge density [29] leading to 
a higher electrophoretic mobility. 
Efect of pH on the electrophoretic mobility: he efect of pH 
on the electrophoretic mobility of p(NIPAM)–co-5% LY in 1 × 10-4 
M NaCl at 25°C is shown in Figure 8. he data of the electrophoretic 
mobility versus pH shown in Figure 8 are comparable to those of the 
particle size shown in Figure 5. As discussed above (point 3.1.1.2), the 
electrophoretic mobility increases around the pK
a
 of LY (5.7 (0.9)) due 
to the deprotonation of the amino group of the aniline [1] (Figure 2) 
that causes an increase of the net negative charge on the particle surface. 
Fluorescence spectroscopy 
he luorescence spectra of 0.01 µg/mL LY, 0.2 µg/mL p(NIPAM) 
and 0.2 µg/mL p(NIPAM-co-5% LY) excited at 430 nm at 25°C and 
45°C at pH 3 and 7 are shown in Figures 9 and 10. 
he emission spectra of lucifer yellow at pH 7 at temperatures 25°C 
and 45°C (Figure 9) and at 25°C pH 3 and 7 (Figure 10) display an 
emission band at 532 nm which is comparable to the reported emission 
wavelength of lucifer yellow at 540 nm [17]. he emission spectra of 
p(NIPAM)-co-5% LY at pH 3 and 7 and at 25°C and 45°C (Figures 9 
and 10) show an emission band at 520 nm. Accordingly, a blue shit is 
observed when the luorophore LY was incorporated into p(NIPAM). 
his is due to the change in the environment around the LY such as 
the electronic cloud in the polymer particle p(NIPAM) as well as the 
polarity of the solvent [18]. he shit of the emission band also provides 
evidence (together with the DLS and IR) of the incorporation of LY in 
the new nanoparticle. 
Efect of addition of lucifer yellow: he concentration of LY used 
for the luorescence spectra in Figures 9 and 10 (0.01 µg/mL) is the 
theoretical concentration of LY incorporated in 0.2 µg/mL p(NIPAM-
co-5% LY) (5%), in other words, it is the concentration of LY added 
during the synthesis of p(NIPAM)-co-5% LY, and was selected to give 
a qualitative comparison of the emission spectrum intensity. However, 
the luorescence intensity of LY is signiicantly higher than that of 
p(NIPAM-co-5% LY) which suggests that either not all the LY added 
during the synthesis reaction is incorporated in the new particle, or 
the quantum yield of LY was quenched by the p(NIPAM) particles, 
or other environmental conditions such as solvent polarity [18]. he 
second suggestion is supported by Furstenberg et al. [18] who studied 
the excited state dynamics of lucifer yellow and concluded that LY is 
an environment sensitive probe whose luorescence dynamics change 
in the presence of proteins and by changing the solvent. hey also 
concluded that the luorescence of LY is quenched by amino acids. 
Given the fact that both proteins and polymer particles are considered 
as large complex molecules/particles, it is a possibility that polymer 
particles might have similar quenching efect on the luorescence of LY. 
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p(NIPAM) does not show an emission band in a similar region or 
of a similar intensity. On the other hand, it shows some luorescence 
intensity (of much lower magnitude than p(NIPAM)-co-5% LY 
which is thought to be due to light scattering [33]. his is a common 
characteristic of colloidal dispersions that is related to particle size. he 
turbidity of colloidal dispersions is due to the intense light scattering 
by its particles. he size and shape of the scattering particles are the 
main factors afecting the intensity of the scattered light. If a colloidal 
nanogel sample is placed in a UV spectrophotometer and a beam of 
light is passed through it, a fraction of the light will be scattered as it 
passes through the sample. While measuring luorescence of p(NIPAM) 
and p(NIPAM)-co-5% LY, the scattered light from the particles can 
partially interfere with the luorescence emission. 
Efect of temperature: he efect of temperature on the luorescence 
of LY, p(NIPAM) – co- 5% LY and p(NIPAM) can be compared using 
Figure 9. In 1852, Sir G. G. Stokes observed that luorescence emission 
generally occurs at lower energies and longer wavelengths than that of 
the absorption [34]. In the case of LY, the emission band at pH 7 at both 
25°C and 45°C are similar λ
max
, band shape and intensity. his indicates 
that the efect of internal conversion (due to temperature change) 
on the Stokes shit is minimal. In terms of luorescence intensity, no 
signiicant diference between the luorescence at 25°C and 45°C is seen 
(Figure 9). he percentage change in luorescence intensity between 
both temperatures is 4% at pH 3 and 1.6% at pH 7. 
In the case of p(NIPAM)–co-5% LY, the emission bands at 25°C 
and 45°C (both at pH 7) show similar λ
max
 and band shape. On the other 
hand, a change in the luorescence intensity is observed by changing 
the temperature (Figure 9). he percentage change in the luorescence 
intensity was 11.7% at pH 3 (3 times higher than that of LY) and 
14.6% at pH 7 (9 times higher than that of LY). his can be attributed 
to diferent factors such as the change in particle size by changing the 
temperature from below to above the VPTT (Figure 5) which changes 
the luorophore density and accordingly the luorescence intensity. 
It is worth mentioning that the particle size of p(NIPAM)-co-5% LY 
decrease by 43% when the temperature increases from 25°C to 45°C at 
pH 3 and 7. he change in temperature can also cause a change in the 
quantum yield of luorescence due to change in solvent properties such 
as solvent polarity [18,35]. For p(NIPAM), the particles deswell when 
the temperature exceeds the VPTT (35°C), thus at 45°C, they acquire a 
de-swollen coniguration and the dispersion is more turbid. his boosts 
the light scattering efect which is shown here as higher luorescence 
intensity. 
Efect of pH: Lucifer yellow is a pH insensitive luorescent probe 
[36]. his agrees with the results shown in Figure 10 where the emission 
bands of LY at same temperature (25°C ) and diferent pH values (3 and 
7) are similar (same λ
em
). he same result is also shown for p(NIPAM)-
co-5% LY. 
he luorescence intensity of LY is afected by the change in 
pH (Figure 10). his can be due to diferent factors that afect the 
quantum yield of the luorophore lucifer yellow. hese include; the 
change of the polarity of the surrounding polymer (p(NIPAM)) and 
its electrophoretic mobility which afects the polarity of the solvent 
[18]. Changing the solvent polarity highly afects the luorescence 
lifetime which in return afects the quantum yield [18,37,38]. Also, the 
change in particle size (including expel and uptake of solvent) causes a 
dramatic change in the surrounding local environment. Other factors 
that can cause a change of the luorescence intensity by changing the 
pH include; change in the rate of solvent relaxation and internal charge 
(proton) transfer [18]. 
Microscopy
Scanning Electron Microscopy (SEM) and Fluorescence 
microscopy, the nanoparticles were examined using SEM (Figure 
11) and luorescence microscopy (Figure 12). Figure 11 show that the 
particles are spherical, monodispersed and their average size is 120 nm 
which is comparable to that shown by DLS at deswollen state (Figure 
5). he luorescence microscopy (Figure 12) also conirms the results of 
SEM where the particles are shown to be spherical and monodispersed 
as well as luorescent. Figure 12 supports the suggestion that LY is 
Figure 11: SEM pictures of p(NIPAM-co-5% LY) at pH 3 (x 45,000).
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Figure 9: Fluorescence spectra of 0.01 µg/mL LY, 0.2 µg/mL p(NIPAM-co-5% 
LY) and 0.2 µg/mL p(NIPAM) excited at 430 nm at pH 7 at temperatures 25°C 
and 45°C.
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Figure 10: Fluorescence spectra of 0.01 µg/mL LY, 0.2 µg/mL p(NIPAM-co-5% 
LY) and 0.2 µg/mL p(NIPAM) excited at 430 nm at 25°C at pH 3 and 7.
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incorporated in the p(NIPAM-co-5% LY) nanoparticles and that they 
are luorescent. Accordingly, it can be suggested that these particles can 
be traced in the human body (given their luorescence) which can serve 
as a diagnostic tool. Researches have tried incorporating luorescent 
dyes into nanogels [39,40], on the other hand, there are no up-to-date 
data showing luorescence microscopy images of luorescent nanogels. 
Toxicity studies 
p(NIPAM) based nanoparticles have been studied for a number of 
years [41-45]. Many applications have been suggested for this polymer 
due to its ability to change its physico-chemical properties according 
to the change in environmental conditions [3,4]. Considering that 
the VPTT of p(NIPAM) nanoparticles is 33-35°C [3] which is very 
close to the human body temperature, many researchers investigated 
the possible use of p(NIPAM) nanoparticles in drug delivery [8,46-
48], delivery of stem cells [49] and other biomedical applications 
such as tissue engineering [27], biomedical implants [50], treatment 
of dentinal hypersensitivity [3] and wound dressings [51,52]. A very 
important point to consider in this case is the toxicity of NIPAM based 
nanoparticles; on the other hand, not many reports are available in this 
context to date. 
In 2010, Naha et al. [53] studied the cyto- and geno-toxicity of 
p(NIPAM) nanoparticles (within a concentration range of 25-1000 
mg/L) on two diferent mammalian cell lines, SW480 (colon) and 
HaCaT (dermal cell line). he viability of cells (both cell lines) ater 24, 
48, 72 and 96 hours were shown to be 100%. Also, the geno- and eco-
toxicity [54] data conirmed the results of the cytotoxicity suggesting 
that p(NIPAM) nanoparticles have an excellent bioavailability proile 
in vitro. Naha et al. [53] have further studied p(NIPAM) based 
nanoparticles inside cells and concluded that the particles enter the 
cells and are localised in the lysosomes. 
he cytotoxicity and uptake of p(NIPAM) based nanoparticles 
with incorporated hyperbranched polyglycerol (HPG) was investigated 
by Cuggino et al. [55]. he cytotoxic efect of p(NIPAM)-co-HPG 
nanoparticles on epithelial human lung cancer cell line A549, human 
hematopoietic cells U-937, and human epidermoid carcinoma cells 
A431. Results suggest that doses above 0.5 mg/mL are required to cause 
adverse efects on the cells. It is also worth mentioning that the particle 
could penetrate the cell membrane of lung cancer cells A549 incubated 
at 37°C and were distributed in the perinuclear region [55]. 
Herein, the efect of dextran, NIPAM monomer, p(NIPAM), 
p(NIPAM-co-5% LY) and PEI on the cell viability of both HeLa and 
Vero cell lines is reported. HeLa cells are human epithelial cells of a 
strain maintained in tissue culture since 1951 and used in research, 
especially in virology. he original cells were provided by cervical 
carcinoma of Henrietta Lacks [56]. Vero cells are taken from the 
kidneys of the African green monkey, Cercopithecus aethiops sabaeus, 
and used to grow certain viruses for vaccine production [57]. 
Figure 13 shows the efect of diferent concentrations (concentration 
range between 0.03 µg/mL to 3 mg/mL) of dextran, NIPAM monomer, 
p(NIPAM), p(NIPAM-co-5% LY) and PEI on the cell viability of HeLa 
cells. he Figure shows that the efect of dextran (used as a negative 
control) on the cell viability was minimal as the cells showed over 
90% viability across the whole range of concentrations. On the other 
hand, PEI (used a positive control) shows cell viability above 80% at 
concentrations less than 0.003 mg/mL. When the concentration further 
increases, the cell viability signiicantly decreases till it reaches 20% at 
a concentration of 0.03 mg/mL. In spite of its reported toxicity [58,59]. 
PEI is widely researched as one of the main non-viral vectors for gene 
therapy [60]. hese results are comparable to those of Zhizhong et al. 
[61] who studied the cytotoxicity of linear 25 KD PEI (known to be less 
toxic than branched PEI [58,60,62]) on OS-RC-2 cell line and reported 
that cell viability under 30 μg/mL of 25 kD PEI was 50%. For 2 kD PEI, 
half of the cells were viable when the concentration was 200-300 μg/
mL. Similar results were also shown by homas et al. [63] who reported 
that less than 50% of COS-7 cells were viable when the concentration of 
25 kD PEI was more than 20 μg/mL while less than 5% of the cells were 
viable when its concentration was above 35 μg/mL. 
Despite its reported cytotoxicity [58,60-64], the use of PEI has been 
studied for biological applications such as gene delivery [59,61,65,66], 
nucleic acid delivery [62,63,67-69], drug delivery [64], cosmetics [70] 
and tissue engineering [71]. In 2012, Wegmann et al. [72] claimed 
that PEI is a potent mucosal adjuvant for human use and suggested 
that further investigation for improvement of potency and safety 
of PEI as an adjuvant suggests promising results. Many attempts to 
decrease the cytotoxicity of PEI by conjugation with other molecules 
have been varied out. hese aim at turning PEI into a bioequivalent 
delivery system [61-63,68,69]. Similarly, it can be suggested that the 
conjugation of acrylamide and its derivative NIPAM into p(NIPAM) 
based particles can yield particles with signiicantly lower toxicity. It 
is also worth mentioning that PEI is currently commercially available 
(in the form of PEI-HCl) in a drug in the German market known as 
‘Epipak’ used for mouth disorders [73].
he main challenge for the use of NIPAM based particles as 
drug delivery systems is its toxicity. he fact that the main monomer 
NIPAM includes acrylamide group which is known for its toxicity [74], 
suggests that the polymerised particle and/or its metabolic products 
(such as NIPAM monomer and/or acrylamide) might acquire the same 
properties. Accordingly, the toxicity of the new particle p(NIPAM-
co-5% LY), p(NIPAM) and the monomer was tested. In Figure 13, 
p(NIPAM) shows cell viability over 80% up to a concentration 3 
mg/mL while NIPAM monomer showed a high cell viability (over 
80%) for concentration equal to, or less than, 0.3 mg/mL. Above this 
concentration, NIPAM monomer shows considerably less viability 
untill it reaches 10% at a dosing concentration of 3 mg/mL.
For p(NIPAM-co-5% LY) particles, the results show that the cell 
viability is around 80% or higher up to 3 mg/mL. his suggests that 
p(NIPAM-co-5% LY) is suitable for medical and/or pharmaceutical 
use when used within the speciied concentrations. Similar results for 
the efect of the same concentrations of dextran, NIPAM monomer, 
p(NIPAM), p(NIPAM-co-5% LY) and PEI on the cell viability of Vero 
cells. Figure 14 shows that dextran showed cell viability over 80% 
across all the dosing concentrations. PEI showed cell viability over 80% 
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Figure 12: Fluorescence microscopy pictures of 2 µg/mL p(NIPAM-co-5% LY) (x100).
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at concentrations equal to or less than 0.001 mg/mL. Increasing the 
dosing concentration decreased the cell viability till it reached 15% at 
0.01 mg/mL. NIPAM monomer showed high cell viability (between 80 
and 100%) at concentrations equal to, or less than, 0.3 mg/mL. Both 
p(NIPAM) and p(NIPAM-co-5% LY) showed cell viability around 80% 
or more for all the dosing concentrations used.  
Comparing the cytotoxicity (for both HeLa and Vero cells) of 
p(NIPAM-co-5% LY) and p(NIPAM) to that of PEI shows that the 
former particles show a safer toxicity proile. While a concentration 
of (0.7 µg/mL for HeLa and 3 µg/mL for Vero) of PEI killed half of 
the cells (Table 2), 3 mg/mL of the NIPAM based particles kept more 
than 80% of the cells alive. Furthermore, NIPAM monomer which 
is expected to be one of the metabolic products of p(NIPAM) based 
particles has an LC
50
 of 700 µg/mL (for both HeLa and Vero cells) 
which is considerably higher than that of PEI. hus, the results show 
that p(NIPAM) based particles as well as NIPAM monomer (at the 
speciied concentrations) have a safer toxicity proile when compared 
to PEI. Considering the ongoing research and use of PEI in biological 
and pharmaceutical applications (previously discussed) and the 
properties of p(NIPAM) based particles such as temperature, pH, 
ionic strength responsiveness, it is suggested that further research of 
the toxicity of p(NIPAM) based particles as well as modiication of the 
particles can yield very useful and promising systems for biological and 
pharmaceutical applications such as drug delivery, gene therapy and 
treatment of dentinal hypersensitivity.
he biocompatibility of p(NIPAM), p(NIPAM-co-AA) and 
p(NIPAM-co-BA) with skin has been studied by Abu Samah et al. 
[75]. he efects of the three nanoparticles on the expression of 
cyclooxygenase-2 (COX-2) was determined using western blotting 
which showed that the particles have penetrated the skin and the 
keratinocytes of the vital epidermis. p(NIPAM)-co-BA showed 67% 
higher COX-2 expression than the control group which indicates a 
pro-inlammatory response. For p(NIPAM)-co-AA, no signiicant 
modulation in the expression of COX2 was shown, indicating the 
compatibility of the particles with skin. Comparable results were 
obtained for nanoparticles loaded with citric acid solution. Accordingly, 
the authors support the use of the multiresponsive p(NIPAM)-co-AA 
as a triggered or controlled topical drug delivery system.
For in vivo testing, Aslam et al. [76] tested the efect of diferent 
concentrations (0, 0.2, 0.4, 0.6, 0.8 and 1 mg/mL) of 150 nm p(NIPAM) 
on Swiss Albino mice (Mus musculus). Oral p(NIPAM) dispersions 
(with the previously mentioned concentrations) were given to the 
mice daily for 30 days. he results suggest that lower doses (0.2 mg/
mL) had no lethal efect on the mice. Increasing the dose of p(NIPAM) 
(0.4, 0.6 and 0.8 mg/mL), half the mice died in 20-25 days. For 1 mg/
mL p(NIPAM) dispersions, half the mice died in 28 days. he authors 
suggest that p(NIPAM) is tolerable at low doses, on the other hand, the 
accumulation of high doses of the particles (by daily administration of 
1 mg/mL/kg) has a lethal efect in an average of 18 days. 
In 1981, Tanii et al. claimed that the metabolic product of NIPAM 
is acrylamide [77], accordingly, it is very important to consider its 
toxicity while studying the toxicity of NIPAM based particles. Many 
researchers have claimed that acrylamide is toxic [78], some mention 
its neurotoxicity [78], others mention its genotoxicity [78] as well as 
other serious efects such as testicular degeneration, necrosis of the 
liver, congestion of the lungs. Acrylamides are formed when some 
foods including certain nutrients are cooked at certain temperatures 
during grilling, frying and baking [73,79]. A review studying the dose-
response relationship of acrylamide was carried out by Shipp et al. [79], 
the study states that the reference dose (RfD) (safe dose) of acrylamide 
is 0.83 µg/kg/day (considering reproductive efects and genotoxicity) 
and 1.2 µg/kg/day (considering neurotoxicity). he review also claims 
that most of the reports of acrylamide toxicity did not consider very 
important factors such as the smoking state of the patients which is 
extremely important [79]. Considering the RfD mentioned by Shipp 
et al. [79], an adult of average weight 70 kg can safely have 58 µg/day 
of acrylamide. 
Most of the drugs currently available in the market can cause 
diferent kind of toxicities and can even be lethal if administered at 
the wrong dose. It is worth mentioning at this point, that p(NIPAM) 
based particles (if pharmaceutically used) are intended to be used as 
a drug delivery system and not a drug, this might be important while 
calculating the required dose. 
Conclusion
A novel luorescent temperature/pH sensitive particle (p(NIPAM)-
co-5%LY) was successfully synthesized and characterized using 
diferent techniques. At pH 7 and 15°C (the particle is swollen), the 
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Figure 13: Percentage cell viability (after 72 hrs) versus log concentration 
(across conc. Range of 0.03 µg/mL to 3000 µg/mL) of dextran, NIPAM 
monomer, p(NIPAM), p(NIPAM-co-5% LY) and PEI on 1 x 104 HeLa cell/mL.
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Figure 14: Percentage cell viability (after 72 hrs) versus log concentration 
(across conc. range of 0.03 µg/mL to 3000 µg/mL) of dextran, NIPAM monomer, 
p(NIPAM), p(NIPAM-co-5% LY) and PEI on 1 x 104 Vero cell/mL.
Table 2: LC
50
 of dextran, NIPAM monomer, p(NIPAM), p(NIPAM-co-5% LY) and 
PEI on HeLa Vero cells.
LC
50
 on HeLa cells (µg/
mL)
LC
50
 on Vero cells (µg/
mL)
Dextran ≥ 3000
NIPAM monomer 700 (±6) 700 (±6)
p(NIPAM) ≥ 3000
p(NIPAM-co-5% LY) ≥ 3000
PEI 0.7 (±0.2) 3 (±0.9)
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particle size is 250 nm. When the temperature exceeds the VPTT 
(35°C) the particle de-swells to reach 130 nm. hese particle sizes are 
approximately half that of p(NIPAM) at similar conditions. he PdI 
and the intensity peaks of the new nanoparticle dispersion indicate a 
uniform particle size across the dispersion. 
his study only provides initial evidence of the biocompatibility 
of NIPAM based particles and its metabolite at the speciied 
concentrations. NIPAM monomer is more toxic than both p(NIPAM) 
and p(NIPAM-co-5% LY). he two nanoparticles show cell viability 
over 80% (for both cell lines Hela and Vero) up to a concentration of 
3 mg/mL while NIPAM monomer show cell viability over 80% equal 
to or less than 0.3 mg/mL. At concentration of 3 mg/mL, NIPAM 
monomer shows 10% cell viability. hese data add to the few existing 
reports on the toxicity of NIPAM based particles and provide some 
encouragement around their biocompatibility and possible use for 
drug delivery applications.
he advantages (temperature, pH, ionic strength, etc. responsiveness 
and ability to release drugs accordingly) of NIPAM based particles can 
be very useful medically and pharmaceutically. Such advantages can 
at some points be louder than other disadvantages (depends upon 
the case). hese particles can be very useful and lexible drug delivery 
systems that can be used for the treatment of diferent diseases such 
as cancer and diabetes. Further studies about the ability of p(NIPAM) 
based particles to be used for gene and nucleic acid delivery can also 
be considered. 
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